Exercise test may reveal hidden heart dangers in 15,000 patients
NCT ID NCT07534410
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a cardiopulmonary exercise test (CPET) can help predict serious heart problems in people with coronary heart disease. Researchers will review medical records from 15,000 patients and track their health over time. The goal is to see if CPET results are linked to future heart attacks or death.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict heart complications in coronary heart disease patients using a simple exercise test.
- What could go wrong
- This is an observational study, not a treatment trial. It may not prove cause and effect, and results might not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 15,000 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients diagnosed with coronary heart disease in our hospital and who have completed cardiopulmonary exercise testing.
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Our hospital has diagnosed coronary heart disease and conducted cardiopulmonary exercise tests. 2. Patients with complete clinical data. Exclusion Criteria: 1. Uncontrolled heart failure (NYHA classification Ⅲ-IV grade). 2. Complications, such as moderate to severe anemia, tumors and lung diseases. 3. Complicated with valvular heart disease. 4. Unable to reach the anaerobic threshold during exercise.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coronary heart disease (CHD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a traditional chinese medicine injection ease heart failure symptoms?
- Can an AI trained on real heart patients outsmart generic chatbots?
- Can your smartwatch replace a medical heart test? scientists put apple watch to the test
- Yam gruel shows promise for heart health after stent surgery
- Heart patients may need only one blood thinner after balloon treatment, major trial tests
- Heart patients get rehab via smartphone app in new study